Oncogene - Table of Contents alert Volume 31 Issue 44

TABLE OF CONTENTS Volume 31, Issue 44 (November 2012) In this issue Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe The publication of this issue was delayed due to Hurricane Sandy closing our New York offices temporarily. We apologize for any inconvenience caused. Advertisement Please take a look at these scientific reports that recently appeared in EMBO reports:  Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion Cynthia R Coffill, Jayantha Gunaratne et al   Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells Emma Sandilands, Bryan Serrels, Simon Wilkinson & Margaret C Frame    Original Articles Top c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells C-H Yoon, M-J Kim, R-K Kim, E-J Lim, K-S Choi, S An, S-G Hwang, S-G Kang, Y Suh, M-J Park and S-J Lee Oncogene 2012 31: 4655-4666; advance online publication, January 16, 2012; 10.1038/onc.2011.634 Abstract | Full Text Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma J Okubo, J Takita, Y Chen, K Oki, R Nishimura, M Kato, M Sanada, M Hiwatari, Y Hayashi, T Igarashi and S Ogawa Oncogene 2012 31: 4667-4676; advance online publication, January 16, 2012; 10.1038/onc.2011.616 Abstract | Full Text Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP A Bangert, S Cristofanon, I Eckhardt, B A Abhari, S Kolodziej, S Häcker, S H K Vellanki, J Lausen, K-M Debatin and S Fulda Oncogene 2012 31: 4677-4688; advance online publication, January 23, 2012; 10.1038/onc.2011.614 Abstract | Full Text Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer S Samanta, V M Sharma, A Khan and A M Mercurio Oncogene 2012 31: 4689-4697; advance online publication, January 23, 2012; 10.1038/onc.2011.620 Abstract | Full Text Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1 A Fassl, K E Tagscherer, J Richter, M Berriel Diaz, S R Alcantara Llaguno, B Campos, J Kopitz, C Herold-Mende, S Herzig, M H H Schmidt, L F Parada, O D Wiestler and W Roth Oncogene 2012 31: 4698-4708; advance online publication, January 16, 2012; 10.1038/onc.2011.615 Abstract | Full Text A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest S P Angus and J R Nevins Oncogene 2012 31: 4709-4717; advance online publication, January 16, 2012; 10.1038/onc.2011.622 Abstract | Full Text Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum–DNA adduct repair K Kudo, E Gavin, S Das, L Amable, L A Shevde and E Reed Oncogene 2012 31: 4718-4724; advance online publication, January 23, 2012; 10.1038/onc.2011.610 Abstract | Full Text Short Communication Top Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesis C U Lago, S M Nowinski, J E Rundhaug, M E Pfeiffer, K Kiguchi, K Hirasaka, X Yang, E M Abramson, S B Bratton, O Rho, R Colavitti, M A Kenaston, T Nikawa, C Trempus, J DiGiovanni, S M Fischer and E M Mills Oncogene 2012 31: 4725-4731; advance online publication, January 23, 2012; 10.1038/onc.2011.630 Abstract | Full Text Corrigendum Top Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness P Zhang, Y Yang, R Nolo, P A Zweidler-McKay and D P M Hughes Oncogene 2012 31: 4732; 10.1038/onc.2012.429 Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.